| Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459) |
|---|
| 07/26/2006 | EP1682538A1 Biaryl linked hydroxamates: preparation and pharmaceutical applications |
| 07/26/2006 | EP1682524A1 Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 07/26/2006 | EP1682522A1 A process for the manufacture of zonisamide |
| 07/26/2006 | CN1266122C Microwave method for synthesizing 2,6-ramification of dicyan aniline |
| 07/25/2006 | US7081539 One-pot process for the preparation of 1,2-benzisoxazole-3-methanesulfonamide |
| 07/25/2006 | US7081538 Substituted isoxazolines and their use as antibacterial agents |
| 07/25/2006 | CA2133140C Isoxazole derivatives |
| 07/20/2006 | WO2006076706A1 Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity |
| 07/20/2006 | US20060160832 Nitrogen-containing aromatic derivatives |
| 07/20/2006 | US20060160773 Combretastatin derivatives with cytotoxic action |
| 07/20/2006 | CA2594860A1 Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity |
| 07/19/2006 | EP1680411A2 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups |
| 07/19/2006 | CN1805744A New n-hydroxy-4-(3-phenyl-5-methyl-isoxazole-4-yl)-benzenesulfonamide solvates |
| 07/18/2006 | US7078421 Substituted phenylacetic acids |
| 07/18/2006 | US7078403 Antiviral agents |
| 07/13/2006 | WO2006074330A2 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 07/13/2006 | WO2006074244A2 Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 07/13/2006 | WO2006042478A8 Small-molecule inhibitors of coronaviral main protease, their preparation and use |
| 07/13/2006 | WO2005112945A3 Synthesis of tetracyclines and analogues thereof |
| 07/13/2006 | CA2594116A1 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 07/13/2006 | CA2594098A1 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 07/12/2006 | EP1678123A1 Tetrahydro-naphthalene and urea derivatives |
| 07/12/2006 | CN1263745C Aryl fused azapolycyclic compounds |
| 07/11/2006 | US7074952 Synthesis of taxol enhancers |
| 07/11/2006 | US7074820 Amidino derivatives and their use as thrombin inhibitors |
| 07/06/2006 | WO2006071184A1 Aryl sulphonamide modulators |
| 07/06/2006 | WO2006069685A1 Substituted oxyarenes |
| 07/06/2006 | WO2006069656A1 Fused bicyclic carboxamide derivatives for use as cxcr2 inhibitors in the treatment of inflammation |
| 07/06/2006 | WO2005108347A3 Substituted enaminones, their derivatives and uses thereof |
| 07/06/2006 | US20060148858 1, 2-Azole derivatives with hypoglycemic and hypolipidemic activity |
| 07/06/2006 | CA2592430A1 Fused bicyclic carboxamide derivatives for use as cxcr2 inhibitors in the treatment of inflammation |
| 07/05/2006 | EP1676834A1 Fused bicyclic carboxamide derivates for use as CXCR2 inhibitors in the treatment of inflammation |
| 07/05/2006 | EP1675844A1 Phenyl carboxamide and sulfonamide derivatives for use as 11-beta-hydroxysteroid dehydrogenase |
| 07/05/2006 | EP1675836A1 Derivatives of 4-phenylthiazoles and 4-phenylimidazoles and the use thereof as medicaments for treating neurodegenerative diseases, pain and epilepsy |
| 07/05/2006 | EP1675585A2 Large conductance calcium-activated k channel opener |
| 07/04/2006 | US7071222 Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and N-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide |
| 07/04/2006 | US7071212 N-(4-carbamimidoyl-phenyl)-glycine derivatives |
| 06/29/2006 | WO2006068092A1 Process for production of (4,5-dihydroisoxazol-3-yl)thio- carboxamidine salts |
| 06/29/2006 | WO2006067472A1 Parp inhibitors |
| 06/29/2006 | US20060142612 Arylsulfonamide derivatives |
| 06/29/2006 | US20060142359 Cyclopenta[c]isoxazole-3-amines used as protective agents for materials |
| 06/29/2006 | US20060142277 Substituted aralkyl derivatives |
| 06/29/2006 | CA2592092A1 Nonnucleoside inhibitors of hiv-1 reverse transcriptase |
| 06/28/2006 | EP1674097A1 Compounds effecting glucokinase |
| 06/28/2006 | EP1673357A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 06/28/2006 | EP1673356A1 Substituted benzylaminoalkylene heterocycles |
| 06/28/2006 | EP1673342A2 Amides that inhibit vanilloid receprot subtype 1 (vr1) receptor |
| 06/28/2006 | EP1673339A2 Heterocyclic inhibitors of mek and methods of use thereof |
| 06/28/2006 | EP1673075A2 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 06/28/2006 | CN1795175A Acetylene derivatives as inhibitors of histone deacetylase |
| 06/28/2006 | CN1261404C Method for producing beta ketoenol esters |
| 06/27/2006 | US7067538 monocyte chemoattractant protein-1; a bis(phenyl) sulfonyl or sulfonamido ketone or dihydroxy compound; antiinflammatory, anticholesterol, antiarthritic agents; immunotherapy; transplant rejection |
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/27/2006 | CA2238633C Alpha-substituted arylsulphonamido hydroxamic acids as tnf-alpha and matrix metalloproteinase inhibitors |
| 06/22/2006 | US20060135770 PARP inhibitors |
| 06/22/2006 | US20060135582 Process for the preparation of benzo [d] isoxazol-3-yl-methanesulfonic acid and the intermediates thereof |
| 06/22/2006 | US20060135580 One step reaction of compound such as 3,5-dimethyl-isoxazole with butlyllithium and (3,5-di-tert-butyl)-4-hydroxybenzaldehyde, recrystallization/dehydration alcohol in the presence of a base to give (E)-5-[2-(3,5-di-tert-butyl-4-hydroxyphenyl)vinyl]-3-methylisoxazole |
| 06/22/2006 | US20060135577 EDG (Endothelial differentiation gene)-2 antagonist; chronic asthma, glomerular nephritis, obesity, prostate hyperplasia, arteriosclerosis, atopic dermatitis; (1) 3-(N-((2-(2-((4-chlorobenzylamino)carbonyl)phenyl)phenyl)carbonyl)-N-(2-(2-methoxyphenyl)ethyl)amino)propanoic acid |
| 06/22/2006 | US20060135487 Piperazine derivatives and their use as anti-inflammatory agents |
| 06/21/2006 | EP1301469B1 Preparation of 4-thioalkylbromobenzene derivatives |
| 06/21/2006 | EP1049662B1 Inhibitors of alpha4 mediated cell adhesion |
| 06/21/2006 | CN1260218C PDF enzyme inhibitor-hydroxamic acid serial compounds, synthetic method and use thereof |
| 06/20/2006 | CA2259183C Fluorous reaction and separation systems |
| 06/15/2006 | WO2006062249A1 Substituted heterocyclic compound and thrombopoietin receptor activator |
| 06/15/2006 | WO2006062093A1 Novel anthranilic acid derivative or salt thereof |
| 06/15/2006 | US20060128759 Substituted isoxazole derivatives and their use in pharmaceutics |
| 06/15/2006 | US20060128670 Pesticidally active ketone and oxime derivatives |
| 06/15/2006 | CA2588633A1 Novel anthranilic acid derivative or salt thereof |
| 06/14/2006 | EP1669069A1 Compounds effecting glukokinase |
| 06/14/2006 | EP1669068A1 Compounds effecting Glucokinase |
| 06/14/2006 | EP1667955A2 Cycloalkylidene compounds as modulators of the estrogen receptor |
| 06/14/2006 | EP1667647A2 Monocyclic and bicyclic lactams as factor xa inhibitors |
| 06/14/2006 | EP1309315B1 Rapidly disintegrating oral formulation of valdecoxib |
| 06/14/2006 | CN1259307C Acylated indanyl amines and their use as pharmaceuticals |
| 06/13/2006 | US7060817 Sulfonamide anions as catalysts for NCO oligomerization |
| 06/13/2006 | US7060710 Isoxazole pyrazoloindane derivatives as cognition enhancing GABAA α5 subtype ligands |
| 06/13/2006 | US7060700 Amide derivatives useful as inhibitors of the production of cytokines |
| 06/08/2006 | WO2006059744A1 ACTIVATOR OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR δ |
| 06/08/2006 | WO2006059149A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
| 06/08/2006 | WO2005120584A3 Radiolabeled arylsulfonyl compounds and uses thereof |
| 06/08/2006 | US20060122242 2-Aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
| 06/08/2006 | US20060122231 Such as N-(4-tert-butylphenyl)-4-(2-pyridinyl)benzamide for treatment of urinary incontinence, pain, inflammatory thermal hyperalgesia, and/or bladder overactivity |
| 06/08/2006 | US20060122221 N-[4-methyl-3-(3-piperidin-4-yl-1,2-benzisoxazol-6-yl)phenyl]-2-pyrrolidin-1-ylisonicotinamide; rheumatoid arthritis |
| 06/08/2006 | US20060122183 Synergistic; side effect reduction; melanomas; toxicity; 2,5-Dimethoxythiobenzoic Acid N-methylhydrazine; anticancer |
| 06/08/2006 | US20060122166 Chemokine receptors; inhibition of HIV replication; acquired immune deficiency syndrome (AIDS); cis N-(4-{2-[3-(2-methyl-1H-benzimidazol-1-yl)-8-azabicyclo[3.2.1]oct-8-yl]ethyl}-4-phenylcyclohexyl)-1H-pyrazole-4-carboxamide |
| 06/08/2006 | CA2589010A1 Biaryloxymethylarene carboxylic acids |
| 06/08/2006 | CA2588864A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
| 06/07/2006 | EP1664031A2 Adamantane and azabicyclo-octane and nonane derivatives process of their preparation and their use as dpp-iv inhibitors |
| 06/07/2006 | EP1664000A1 Isoxazoles as peptide deformylase inhibitors |
| 06/07/2006 | EP1663999A2 Inhibitors of phosphodiesterase type-iv |
| 06/07/2006 | EP1663204A2 C-kit modulators and methods of use |
| 06/07/2006 | EP1259489B1 Aryl fused azapolycyclic compounds |
| 06/07/2006 | CN1784396A P38 inhibitors and methods of use thereof |
| 06/07/2006 | CN1781915A Method for producing an oxazolylethanol derivative |
| 06/01/2006 | WO2006030211A3 Acyclic sulphonamides |
| 06/01/2006 | US20060116409 Phospholipase inhibitors |
| 06/01/2006 | US20060116377 Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses |
| 06/01/2006 | US20060116374 substituted bis/thiohydrazide amide compound; synergistic effect with taxol or taxotere, anticancer agents, side effect reduction |
| 06/01/2006 | CA2588607A1 Carbazole, carboline and indole derivatives useful in the inhibition of vegf production |
| 05/31/2006 | EP1661569A1 Compounds effecting glucokinase |